Dr. Savitri R. Motiram, MD

Dr. Motiram practices at Renaissance Heaith Care in New York, New York.

Dr. Motiram's NPI, 1912944398, was assigned on June 2, 2006. Dr. Motiram graduated from The Peoples' Friendship University of Russia Faculty of Medicine in 1989. Dr. Motiram holds New York license 215653.

Dr. Motiram's primary practice is Renaissance Heaith Care, at 215 W 125th St, New York, NY 10027 in New York County. The practice phone is (212) 932-6588.

Dr. Motiram's primary practice is Renaissance Heaith Care in New York, New York. The medical group on file is AdvantageCare Physicians. Dmand AI also links Dr. Motiram to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Motiram practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Motiram's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Motiram is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Motiram's licenses on file in 2 states: New York and New Jersey.

Dmand AI lists aneurysm, asthma, atrial fibrillation and flutter, bronchitis, cerebrovascular disease, chronic anemia, chronic diabetes and chronic hypertension among the conditions Dr. Motiram treats.

CMS data shows 425 Medicare services from Dr. Motiram across 9 procedure codes in 2024, for 108 Medicare patients. Medicare paid $27,228 for them. Every service was in an office.

CMS counts 108 Medicare patients who saw Dr. Motiram in 2024. The largest group is 65 to 74, with 54 patients. 72% of them have high blood pressure, and 66% have high cholesterol. 23% are also on Medicaid. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Motiram's median patient age at 60, with 74% women.

In 2024, Dr. Motiram wrote 9,866 Medicare Part D claims for 562 patients. 83% of them were for generic drugs. CMS names the drug for 9,106 of them, across 139 drugs with 11 or more claims each, at $910,029 in total drug cost. In 2023, CMS named 7,969 claims across 127 drugs.

Dr. Motiram accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 4 general payments to Dr. Motiram from 3 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. Abbott Laboratories paid the most, $146.

Dmand AI lists 2 awards for Dr. Motiram, most recently NCQA PCMH in 2014.

Dr. Motiram graduated from The Peoples' Friendship University of Russia Faculty of Medicine in 1989.

Dr. Motiram is in network with 16 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.